Skip to content
Homepage
Author:
WuXi XDC
Posted Date:
September 21, 2026
WuXi XDC Celebrates GMP Release of Singapore Site, Ushering in a New Era of Global Expansion
WuXi XDC
September 21, 2026
WuXi XDC Out-Licenses WuXiTecan-2 Payload-Linker Technology Platform to Ona Therapeutics to Advance Novel ADC Research and Development
WuXi XDC
September 17, 2026
WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership
WuXi XDC
August 24, 2026
WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence
WuXi XDC
August 18, 2026
